Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | April 12, 2024 | April 15, 2024 |
| Gen Digital Inc.GEN · Entity 2098 | Director | September 09, 2026 | September 11, 2026 |
| LAM RESEARCH CORPLRCX · Entity 1467 | Director | June 12, 2026 | June 15, 2026 |
| MACERICH COMAC · Entity 3712 | Director | May 30, 2024 | June 04, 2024 |
| Nutanix, Inc.NTNX · Entity 3296 | Director | December 12, 2025 | December 17, 2025 |
| Option Care Health, Inc.OPCH · Entity 4126 | Director | May 20, 2026 | May 22, 2026 |
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | January 29, 2009 | January 30, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date April 12, 2024 · Filed April 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,372.146 |
Reported balance
After 2024-04-12 transaction · row 2
1 source rowRow 2 · 2024-04-12 · Grant · Acquired 72.546 · Balance 53,372.146 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. |
| Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security | Direct | 1,543.4018 |
Reported balance
After 2024-04-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-12 · Grant · Acquired 7.8111 · Balance 1,543.4018 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends. |
| Common StockSEC Table I · non-derivative | IndirectBy The Brandt Family Trust U/a Dtd 06/09/2006 | 5,400 |
Reported balance
Holding disclosure · report date 2024-04-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,400 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.
F3: Comprised of phantom stock acquired as a result of accrued dividends.
Gen Digital Inc.
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,072 |
Ending reported balance
After 2026-09-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-09 · Grant · Acquired 9,072 · Balance 17,894 F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date. Row 2 · 2026-09-09 · Gift · Disposed 8,822 · Balance 9,072 F2: Stock transfer to family trust over which the reporting person has voting power. |
| Common StockSEC Table I · non-derivative | IndirectThe Brandt Family Trust | 78,506 |
Reported balance
After 2026-09-09 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-09 · Gift · Acquired 8,822 · Balance 78,506 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date.
F2: Stock transfer to family trust over which the reporting person has voting power.
LAM RESEARCH CORP
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,705 |
Last balance in matching sequence
After 2026-06-12 transaction · row 17
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
17 source rowsRow 1 · 2026-06-12 · Sale · Disposed 300 · Balance 198,905 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 2 · 2026-06-12 · Sale · Disposed 1,393 · Balance 197,512 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 3 · 2026-06-12 · Sale · Disposed 1,100 · Balance 196,412 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 4 · 2026-06-12 · Sale · Disposed 3,828 · Balance 192,584 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 5 · 2026-06-12 · Sale · Disposed 1,906 · Balance 190,678 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 6 · 2026-06-12 · Sale · Disposed 819 · Balance 189,859 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 7 · 2026-06-12 · Sale · Disposed 2,708 · Balance 187,151 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 8 · 2026-06-12 · Sale · Disposed 2,345 · Balance 184,806 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 9 · 2026-06-12 · Sale · Disposed 2,300 · Balance 182,506 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 10 · 2026-06-12 · Sale · Disposed 1,200 · Balance 181,306 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 11 · 2026-06-12 · Sale · Disposed 5,803 · Balance 175,503 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 12 · 2026-06-12 · Sale · Disposed 4,030 · Balance 171,473 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 13 · 2026-06-12 · Sale · Disposed 4,198 · Balance 167,275 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 14 · 2026-06-12 · Sale · Disposed 5,037 · Balance 162,238 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 15 · 2026-06-12 · Sale · Disposed 8,233 · Balance 154,005 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 16 · 2026-06-12 · Sale · Disposed 7,700 · Balance 146,305 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 17 · 2026-06-12 · Sale · Disposed 1,600 · Balance 144,705 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive
F3: The amount reported includes shares subject to unvested restricted stock units.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive
F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive
F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive
F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive
F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive
F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive
F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive
F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive
F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive
F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive
F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive
F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive
F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive
F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive
F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive
MACERICH CO
Report date May 30, 2024 · Filed June 04, 2024 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,978 |
Reported balance
Holding disclosure · report date 2024-05-30 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 62,978 |
Nutanix, Inc.
Report date December 12, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 6,698 |
Reported balance
After 2025-12-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-12-12 · Grant · Acquired 4,588 · Balance 6,698 F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.
F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.
Option Care Health, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,999 |
Ending reported balance
After 2026-05-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 19,356 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 2,643 · Balance 21,999 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.
F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.
VERTEX PHARMACEUTICALS INC / MA
Report date January 29, 2009 · Filed January 30, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2009-01-29 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2009-01-29 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2009-01-29 · Exercise / conversion · Acquired 7,500 · Balance 27,500 Row 3 · 2009-01-29 · Sale · Disposed 27,500 · Balance 0 F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $13.22 · Expires 2013-05-20 | Direct | 0 |
Reported balance
After 2009-01-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-01-29 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Fully vested. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.09 · Expires 2015-05-31 | Direct | 0 |
Reported balance
After 2009-01-29 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-01-29 · Exercise / conversion · Disposed 7,500 · Balance 0 F2: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.
F2: Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 11, 2019 Filed Jan 15, 2019 21:17 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 3.1667 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001994 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458.0726 Underlying: Common Stock · 3.1667 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:17 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 21.38 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-001994 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,826.776 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 16:43 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-18-000132 · wf-form4_154212737049228.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,790 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 3.5432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030302 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,454.9059 Underlying: Common Stock · 3.5432 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| October 12, 2018 Filed Oct 16, 2018 20:07 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 20.968 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030302 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,805.396 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 13, 2018 Filed Jul 13, 2018 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 18.044 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023184 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,784.428 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 20:03 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 2.7803 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-023398 · form4.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,451.3627 Underlying: Common Stock · 2.7803 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F1 · price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:55 UTC | MACERICH CO MAC · Entity 3712 | GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009029 · edgar.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520 Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:12 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 11,700 | $0.00 Strike: $46.50 | $0.00 |
DisclosureSEC source: 0001127602-18-018815 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Underlying: Common Stock · 11,700 shares Expires 2028-05-23 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:12 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 2,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018815 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,766.384 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| April 13, 2018 Filed Apr 13, 2018 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 13.606 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014541 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,174.384 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: The balance reflects an adjustment to correct a computational error in column 5 of reporting person's Form 4 filed May 25, 2014. Additionally, starting with the 1Q2018 quarterly dividend on restricted stock units, the reporting person's method of reporting restricted stock units and the dividends on restricted stock units has been revised to report such grants and dividends in Table I rather than as previously reported in Table II. Accordingly, the balance includes unvested restricted stock units and accrued dividends previously reported in Table II. Read SEC document |
| April 13, 2018 Filed Apr 16, 2018 20:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 2.5749 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014647 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448.5824 Underlying: Common Stock · 2.5749 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 8.526 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-18-001865 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,424.179 Underlying: Common Stock · 8.526 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1.859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001865 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,861.786 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,196 | $0.00 Strike: $39.39 | $0.00 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · derivative · entry 7 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,196 shares Expires 2018-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,213 | $0.00 Strike: $41.07 | $0.00 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · derivative · entry 6 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,213 shares Expires 2018-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 1,196 | $68.04 | $81,375.84 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · nonDerivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859.927 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 5,213 | $68.04 | $354,692.52 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,055.927 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,196 | $39.39 | $47,110.44 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,268.927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 5,213 | $41.07 | $214,097.91 |
DisclosureSEC source: 0001127602-18-001556 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,072.927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 21:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 1.8982 | $66.57 | $126.36 |
DisclosureSEC source: 0001127602-18-000638 · form4.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446.0075 Underlying: Common Stock · 1.8982 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 00:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-17-000152 · wf-form4_151062079839176.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,440 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 9.37 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029954 · form4.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,415.653 Underlying: Common Stock · 9.37 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 21:10 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 2.044 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029954 · form4.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859.927 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 20:13 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Compensation) · Derivative | 2.1373 | $59.03 | $126.17 |
DisclosureSEC source: 0001127602-17-028910 · form4.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444.1093 Underlying: Common Stock · 2.1373 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 8.631 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002367 · form.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,406.283 Underlying: Common Stock · 8.631 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1.883 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002367 · form.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,857.883 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 20:21 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 1.943 | $64.84 | $125.98 |
DisclosureSEC source: 0001246360-17-002300 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441.972 Underlying: Common Stock · 1.943 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,220 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002032 · form.xml · derivative · entry 5 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,397.652 Underlying: Common Stock · 1,220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted Stock Units (RSUs) convert into Common Stock on a one-for-one basis for no additional consideration. F4 · shares: Comprised of one thousand two hundred fourteen (1,214) vested RSUs plus six (6) RSUs accrued through dividend equivalent rights, each as previously reported in this Table II. F5 · derivative.exercise_date: Restricted Stock Units vest in full one (1) year from date of grant. F5 · derivative.expiration_date: Restricted Stock Units vest in full one (1) year from date of grant. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002032 · form.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 7,300 | $0.00 Strike: $62.73 | $0.00 |
DisclosureSEC source: 0001246360-17-002032 · form.xml · derivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,300 Underlying: Common Stock · 7,300 shares Expires 2027-05-24 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| May 24, 2017 Filed May 26, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002032 · form.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,636 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs). Read SEC document |
| April 14, 2017 Filed Apr 18, 2017 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 10.658 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001604 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,617.652 Underlying: Common Stock · 10.658 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 2.015 | $62.44 | $125.82 |
DisclosureSEC source: 0001246360-17-001545 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,440.029 Underlying: Common Stock · 2.015 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option · Derivative | 2,460 | $0.00 Strike: $44.44 | $0.00 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · derivative · entry 7 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,460 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionStock Option · Derivative | 481 | $0.00 Strike: $36.49 | $0.00 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · derivative · entry 6 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 481 shares Expires 2017-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 2,460 | $64.35 | $158,301.00 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · nonDerivative · entry 5 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,241 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 481 | $64.35 | $30,952.35 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · nonDerivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,701 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 2,460 | $44.44 | $109,322.40 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 21:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 481 | $36.49 | $17,551.69 |
DisclosureSEC source: 0001246360-17-001164 · form.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 21:49 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 10.197 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000186 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606.994 Underlying: Common Stock · 10.197 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 1.928 | $57.73 | $111.30 |
DisclosureSEC source: 0001246360-17-000069 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438.014 Underlying: Common Stock · 1.928 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock and accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 22:26 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-16-000102 · wf-form4_147924875244182.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,480 F1 · balance_after: Amount reported includes shares subject to unvested Restricted Stock Units. Read SEC document |
| October 14, 2016 Filed Oct 18, 2016 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantRSU (Restricted Stock Unit) · Derivative | 9.894 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006971 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,599.797 Underlying: Common Stock · 9.894 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.exercise_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F1 · derivative.expiration_date: Represents dividends on restricted stock units (RSUs) awarded to the reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 04, 2016 Filed Oct 5, 2016 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 348.464 | $59.43 | $20,709.22 |
DisclosureSEC source: 0001246360-16-006945 · form.xml · derivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,436.086 Underlying: Common Stock · 348.464 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock and accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| July 05, 2016 Filed Oct 5, 2016 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 331.84 | $62.33 | $20,683.59 |
DisclosureSEC source: 0001246360-16-006945 · form.xml · derivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087.622 Underlying: Common Stock · 331.84 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock and accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| May 22, 2016 Filed Oct 28, 2016 20:07 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionRSU (Restricted Stock Unit) · Derivative | 1,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-007005 · form.xml · derivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,369.324 Underlying: Common STock · 1,593 shares Expires 2016-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of one thousand five hundred sixty-seven (1,567) vested Restricted Stock Units (RSUs) plus twenty-six (26) DERs. The original Form 4 reported all RSUs and twenty-three (23) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. F2 · shares: This amended Form 4 is filed solely for the purpose of reporting an aggregate of three (3) additional shares of common stock which were accrued through dividend equivalent rights (DERs) and not reported on the original Form 4. F1 · shares: Comprised of one thousand five hundred sixty-seven (1,567) vested Restricted Stock Units (RSUs) plus twenty-six (26) DERs. The original Form 4 reported all RSUs and twenty-three (23) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. Read SEC document |
| May 22, 2016 Filed Oct 28, 2016 20:07 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Exercise / conversionCommon Stock | 1,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-007005 · form.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Comprised of one thousand five hundred sixty-seven (1,567) vested Restricted Stock Units (RSUs) plus twenty-six (26) DERs. The original Form 4 reported all RSUs and twenty-three (23) DERs. RSUs convert into common stock on a 1:1 basis for no additional consideration. F2 · shares: This amended Form 4 is filed solely for the purpose of reporting an aggregate of three (3) additional shares of common stock which were accrued through dividend equivalent rights (DERs) and not reported on the original Form 4. Read SEC document |
| March 22, 2016 Filed Oct 5, 2016 20:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Directors' Deferred Comp) · Derivative | 344.247 | $60.00 | $20,654.82 |
DisclosureSEC source: 0001246360-16-006945 · form.xml · derivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755.782 Underlying: Common Stock · 344.247 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F2 · shares: Comprised of phantom stock and accrued dividends. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Read SEC document |
| November 06, 2015 Filed Nov 10, 2015 22:00 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001631209-15-000003 · primary_doc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,430 F1 · balance_after: Amount reported includes share subject to unvested Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.